Navigation Links
Venugopal Should Not Have Gone Public: Ramadoss

Union Health Minister Anbumani Ramadoss came down heavily on AIIMS Director P Venugopal for accusing him of 'interfering' in the functioning of the premier institute // and threatening to resign, saying he should not have gone public on the issue.

Speaking to PTI, Ramadoss said, 'It is very wrong that he has gone public. If he had any problem, he could have discussed with me. I was and am always available.' Denying that he had interfered in the functioning of AIIMS, he said as president of the institute, he had certain obligations and duties to perform.

'Is performing duty interference?' he asked adding that the charges levelled against him by Venugopal were 'rubbish'.

Justifying the appointment of a dean for AIIMS, he said the post had remained vacant for a long time. 'How could a prestigious institute function without a dean for a long time?' he asked.

Ramadoss said the fund allocation for AIIMS had been hiked from Rs 350 crore to Rs 500 crore during his tenure. He has also made the trauma care centre at the institute functional, besides completing the construction of a building for cancer care.

'If all this is interference, I am glad to interfere,' he said.

Ramadoss said when he had become the Health Minister, the lack of administration in AIIMS was visible. He had taken steps to tone up the administration. The charges against him were a 'continuation' of the anti-quota stir of last month, he said.

(Source:PTI News)

Page: 1

Related medicine news :

1. AIIMS Doctors Seeks Ramadoss Intervention For Venugopal’s Remova
2. AIIMS Director Venugopal Sacked
3. Venugopal will not be Sacked Before Court Verdict: Central Government
4. Delhi High Court Stays Venugopals Removal
5. Normalcy Returns To AIIMS; Venugopal Attends Office
6. AIIMS Official Files Complaint Against Venugopal
7. AIIMS Director Venugopal Removed from Additional Post
8. Court Issues Notice to Venugopal Over Fund Irregularities
9. Babies Should Get Vitamin D Supplement
10. How Much Should Athletes Drink?
11. Angioplasty Should be the Standard
Post Your Comments:

(Date:6/27/2016)... ... 27, 2016 , ... TherapySites, the leading website ... Tennessee Counseling Association. This new relationship allows TherapySites to continue to ... adding exclusive benefits and promotional offers. , "TCA is extremely excited about this ...
(Date:6/27/2016)... , ... June 27, 2016 , ... ... edge technology to revolutionize the emergency ambulance transport experience for the millions of ... of how Uber has disrupted the taxi industry through the use of technology. ...
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal ... personalized through a fitness app. The fitness app plans to fix the two major problems ... offer a one size fits all type program , They don’t eliminate all ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology: